Introduction {#Sec1}
============

When after a period of ischemia blood supply returns to the tissue causing tissue abrasion is reperfusion injury (Grace [@CR14]). During the ischemic period due to the absence of oxygen and essential nutrients a condition occurs, rather than restoration of oxidative damage and inflammation through oxidative stress is caused as a result of the restoration of circulation. Liver ischemia--reperfusion (I/R) injury is well denoted as a notable reason for mortality and morbidity (Glantzounis et al. [@CR13]). It often occurs in liver transplantation (Liu et al. [@CR17]) and resections (Caldwell-Kenkel et al. [@CR3]; Deschênes et al. [@CR7]) where ischemic liver or anoxic injury takes place. It also occurs as a repercussion of hypoxia or insufficient perfusion occurring due to certain conditions that lower blood flow to the liver. Latter materialize in cardiogenic, hemorrhagic with fluid resuscitation (Yamakawa et al. [@CR35]) in abdominal compartment syndromes (Okano et al. [@CR26]) in cardiovascular and laparoscopic surgery (Glantzounis et al. [@CR12]; Moore et al. [@CR21]).

Liver transplantation, I/R injury is pertinent to the growth of primary graft dysfunction (occurrence in 10--25% of grafts) and primary graft non-function (an event in 5% of grafts) (Clavien et al. [@CR6]). High rates of mortality are observed in both conditions. I/R injury elevate the occurrence of graft rejection (Fellstrom et al. [@CR10]). Transplantation or liver resection with steatotic livers is another area where I/R injury affect. Some degree of liver steatosis has been observed in 25% of the western population (Selzner and Clavien [@CR29]), the vast mass of TG inside the cytoplasm, ascribed to the effects of obesity, excess diabetes alcohol, and drugs.

Medicinal plants and phytochemicals have intensified because of potential chemotherapeutic values in animal diseases*. The root of Inula racemosa* (Ir) has been considered to exhibit cardio-protective effect and relieve ischemic pain (Manipuri et al. [@CR18]). Sesquiterpenes, alloalantolactone, isoalantolactone, and alantolactone which are considered for therapeutic potential. Some glycosides, eudesmenes, germacranolides are also present in it. Ir should be considered for future studies as they offer new substitutes to the therapeutic options are very limited for liver diseases (Veteläinen et al. [@CR34]; Kaplowitz [@CR16]; Muthuviveganandavel et al. [@CR24]; Olthoff et al. [@CR27]; Gibson and Dudley [@CR11]; Sylvia and Adam [@CR33]). Several chemically defined molecules have been extracted from natural origins due to strong hepatoprotective activities epitomize an important source for effective liver protective agents. The need for this study exists on this basis.

Materials and methods {#Sec2}
=====================

Chemicals {#Sec3}
---------

Xylazine, ketamine hydrochloride, chloroform, *n*-hexane, dimethyl sulfoxide (DMSO), and spirit were obtained from Sigma-Aldrich (USA). Aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), and lactate dehydrogenase (LDH) enzyme kits were obtained from Bio-Rad (UK). The p53, bax and bcl-2 monoclonal antibody, and HRP-conjugated goat anti-rabbit IgG were purchased from Sigma-Aldrich (St. Louis, MO 63178 USA).

Preparation of plant extract {#Sec4}
----------------------------

Ir was obtained from National Research Institute for Sowa Rigpa (Amchi) Research Centre, Leh-Ladakh, India. Ir (2 kg) were cut into small pieces, shade dried for 7 days. A closed container was used in which Ir was taken and treated in *n*-hexane for about 2 days with infrequent shaking (Mohan and Gupta [@CR20]). Marc was pressed after the n-hexane was strained off and kept for 4 days with infrequent shaking in a hydroalcoholic mixture. Until the formation of brown colored paste, the solution was filtered and concentrated. Two liters of n-hexane and methanol was used.

Gas chromatography-mass spectrometry (GC/MS) analysis {#Sec5}
-----------------------------------------------------

Ir extracts were analyzed using gas chromatography-mass spectrometry (GC/MS, Thermo Fisher Scientific Korea Ltd. Seoul 06177, Korea). Compound identification was based on the retention time values and reported literature for authentic compounds (Kalachaveedu et al. [@CR15]).

Liquid chromatography-mass spectrometry (HPLC/MS) analysis {#Sec6}
----------------------------------------------------------

Component analysis of Ir extracts was performed by liquid chromatography-mass spectrometry (HPLC/MS, Thermo Fisher Scientific Korea Ltd. Seoul 06177, Korea) analysis (Agilent 6500 Series) (So Hyun et al. [@CR32]).

Animals {#Sec7}
-------

Healthy male albino Wistar strain rats were obtained from the animal house, Shangai, China, weighing (180--200 g) was selected for the present study. Animals kept in polypropylene cages, at temperature 25 ± 0.5 °C, relative humidity 60 ± 5% and a photoperiod of 12 h/day. All the animals were handled according to internationally accepted ethical procedures. Ethical approval was obtained from the Ethics Committee of Wenzhou Medical University (Approval No. 201308807).

Induction of hepatic I/R {#Sec8}
------------------------

The foods were removed, and animals fasted before the experiment. Ketamine hydrochloride (100 mg/kg) and xylazine (10 mg/kg) were used to anesthetize animals. Ischemia was induced by clamping the hepatic portal triad. Bulldog clamp was used to clamp the hepatic portal train for 40 min which in turn produced Ischemia. Repercussion was generated through unclamping the triad for 40 min (Manipuri et al. [@CR18]).

Experimental group {#Sec9}
------------------

Animals were divided into four each containing six. Group I: sham, group II: control, group III: I/R + Ir (100 mg/kg) and group IV: I/R + Ir (200 mg/kg). The oral gauge was used for drug administration for the 15 consecutive days.

Collection of blood and liver {#Sec10}
-----------------------------

Blood was collected from all animals through cardiac puncture. Animals were sacrificed by decapitation, and liver tissue was surgically removed and place ice-cold saline and kept at − 20 °C for the further experiments.

Determination of total phenolic contents {#Sec11}
----------------------------------------

The total phenolic contents were determined with use of Folin--Ciocalteu method. Experimental data were expressed as caffeic acid equivalents per mg of dry extract weight (Faten et al. [@CR9]). The total anthocyanin was measured with use of the pH differential method. Experimental data are expressed as mg of dry weight (Shoib and Shahid [@CR30]).

DPPH scavenging activity {#Sec12}
------------------------

α, α-diphenyl-β-picrylhydrazyl (DPPH) reduction was measured by the standard method, and the experimental results are expressed as μg of extract dry weight (Cavin et al. [@CR4]).

ABTS scavenging activity {#Sec13}
------------------------

2,2′-Azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) scavenging activity was measured by the well-known standard method, and the experimental data are expressed as mg of dry extract weight (Re et al. [@CR28]).

Ferric reducing antioxidant power (FRAP) {#Sec14}
----------------------------------------

The reducing ability of extract was determined with use of FRAP analysis, and it was determined by the standard method. Experimental data are expressed as μmol of extract dry weight (Benzie and Strain [@CR2]).

Determination of serum enzymes {#Sec15}
------------------------------

ALT, AST, ALP, and LDH were determined in the serum by using kit (Span Diagnostics Ltd., India) method (Muthuviveganandavel et al. [@CR24]).

Histopathological and biochemical assays {#Sec16}
----------------------------------------

Histopathological studies were conducted with sections (Kedee New, High Guality and Stable Rotary Microtome, Zhejiang Jinhua Kedi Instrumental Equipment Co., Ltd. Zhejiang, China) of liver fixed in formalin and staining was carried out with hydrated tissue sections in 5 μm with Hematoxylin and Eosin (H & E). The sections were observed under a light microscope (Muthuviveganandavel et al. [@CR24]).

Determination of TNF-α and IL-6 content {#Sec17}
---------------------------------------

Tumor necrosis factor-alpha (TNF-α) and interleukin (IL-6) content were determined in the plasma. Enzyme-linked immune sorbent assay (ELISA) method was used to determine IL-6 and TNF-α in the plasma. Briefly, IL-6 and TNF-α present in the plasma to anti-IL-6 and anti-TNF-α monoclonal antibody adsorbed to the microwells. A biotin-conjugated monoclonal anti-IL-6 and anti-TNF-α antibody were incubated with IL-6 and TNF-α antibody. The unbound antibody has been removed through repeated washing with PBS. Then, streptavidin-HRP was incubated with biotin-conjugated anti-IL-6 and anti-TNF-α, and substrate HRP was added to samples. The resultant colored product was measured at 450 nm (Afshari et al. [@CR1]).

Western blot analysis {#Sec18}
---------------------

Cell homogenate was washed with PBS, and lysed with 10 mM Tris--HCl (pH 7.5), 100 mM NaCl, 1% NP-40, 50 mM NaF, 2 mM EDTA (pH 8.0), 10 μg/mL leupeptin, 1 mM PMSF and 10 μg/mL aprotinin. The protein which is present in the lysate was run on SDS-PAGE. PVDF membrane was used for transferring in the SDS-PAGE. TBST was used for the non-specific blocking proteins. The membrane probed for 12 h with an antibody against p53, Bax, and Bcl-2. Membranes were washed twice with TBST and incubated with HRP-conjugated goat anti-rabbit IgG (St. Louis, MO 63178 USA) for 60 min. The protein levels of p53, bax, and bcl-2 were determined by using enhanced chemiluminescence method (Muthuraman et al. [@CR23]).

Immunohistochemical analysis {#Sec19}
----------------------------

Liver tissue was surgically removed from the rat animals following decapitation and rinsed in ice-cold normal saline. Paraformaldehyde was used for fixation of liver and dehydrated with ethanol. Then, tissues were embedded in paraffin wax and dewaxed and rehydrated before sectioning. Sections were made and incubated with mouse anti-p53, anti-bax and anti-bcl-2 (1:300, Abcam, USA) for overnight at 4 °C. After repeated washing with PBS, sections were incubated with HRP-conjugated secondary antibody at 37 °C for 60 min. Sections were counterstained with hematoxylin (Muthuraman and Srikumar [@CR22]).

Statistical analysis {#Sec20}
--------------------

All the experimental values are expressed as a mean ± standard error of the mean (SEM). The control and treated groups were compared using ANOVA (SPSS 15, Chicago, IL, USA). Furthermore, all the groups are compared using Student "t" test. A P \< 0.05 was considered statistically significant.

Results {#Sec21}
=======

The GC--MS analysis was used to get preliminary data on the composition of Ir extracts in the present study. The polarity of the solvents could affect the efficiency of extraction and activity of obtained compounds in the extracts. Ethyl acetate, ethanol, methanol, acetone, and water are most generally solvents for extraction. The compound obtained in the Ir extract is given in Table [1](#Tab1){ref-type="table"}. HPLC/MS provides cost-effective tool for the identification of phenolic compounds. The chemical constituents are expressed on the dry weight basis. The compounds obtained in the Ir extracts are given in Table [2](#Tab2){ref-type="table"}.Table 1Retention time (Rt) of compounds identified in the extract of IrNoConstituentRetention time (min)Identification12-Methoxyethanol15.241Ref, Lib2Nonane, 3-methyl-5-propyl-methyl benzoate16.013Ref, Lib3Alpha-muurolene19.435Ref, Lib42-Phenyl-2-propanol21.618Ref, Lib5Benzene, 1-(1,5-dimethyl-4-hexenyl)-4-methyl-1-butanol22.624Ref, Lib6Hexanal dimethyl acetal23.958Ref, Lib72-Methoxyethanol24.451Ref, Lib81-Pentanol25.223Ref, Lib9Propionitrile, 2-(3-fluorophenylhydrazono)-3-imino-3-(4-morpholyl)- tetradecane36.521Ref, Lib101-Hexanol, 2-ethyl43.536Ref, Lib112-Propenoic acid, 2-methyl-cyclohexyl ester44.321Ref, Lib12Beta elemene51.612Ref, Lib13Benzaldehyde46.622Ref, Lib14Nonane, 3-Methyl-5-propylnonane50.776Ref, Lib15Methyl benzoate53.745Ref, Lib16Benzoic acid52.206Ref, Lib17Acetophenone56.414Ref, Lib18Alpha-amorphene56.494Ref, Lib19Alpha-muurolene55.394Ref, Lib202-Phenyl-2-propanol58.333Ref, Lib21Alpha-selinene59.103Ref, Lib22Beta-selinene61.111Ref, Lib23Azulene62.495Ref, Lib*GC/MS* comparison with GC/MS standard, *Ref* comparison with GC and MS literature values Table 2The compounds obtained in the Ir extractsS.NoName of the constituentsQuantity (mg/100 g)13,5-Dihydroxybenzoic acid-*O*-glucosyl-xyloside13.92Chlorogenic acid33.23Catechin gallate22.54Caffeic acid93.725Alantolactone42.426Kaempherol-7-*O*-dipentoside42.97Galloyl-caffeoylhexose11.98Quercetin-3-*O*-beta-glucopyranoside51.19Dicaffeoyl quinic acid70.3109-*O*-beta-[d]{.smallcaps}-glucopyranosyl-9-hydroxythymol19.2115-*O*-feruloylquinic acid29.812Dihydrocaffeic acid derivative13.213Epicatechin22.7146″-O-malonyl genistein1.6

The total phenolic and anthocyanins contents were determined in the extract of Ir. Total phenolic and anthocyanins contents were 48.26 µg/mg and 39.5 µmol/mg of dry weight respectively (Fig. [1](#Fig1){ref-type="fig"}a). DPPH scavenging activity was 38.6 and 15.4 µg/mg of dry weight in the sham and control group respectively. Treatment of rats with extracts of Ir significantly improved DPPH scavenging activity. DPPH scavenging activity was 21.2 and 31.5 µg/mg of dry weight in the group III and IV respectively (Fig. [1](#Fig1){ref-type="fig"}b, P \< 0.05). ABTS scavenging activity was 89.3 and 39.89 µg/mg of dry weight in the sham and control group respectively. Treatment of rats with extracts of Ir significantly improved ABTS scavenging activity to 49.5 and 76.48 µg/mg of dry weight in the group III and group IV respectively (Fig. [1](#Fig1){ref-type="fig"}c, P \< 0.05). Ferric reducing antioxidant power was 266.6 and 105.34 µmol/mg of dry weight in the sham and control group respectively. Treatment of rats with extracts of Ir significantly improved FRAP to 149.61 and 229.81 µmol/mg of dry weight in the group III and group IV respectively (Fig. [1](#Fig1){ref-type="fig"}d, P \< 0.05).Fig. 1Total phenolic and anthocyanins content in the extract of Ir (**a**). DPPH activity in control and treated rats (**b**). ABTS activity in control and treated rats (**c**). FRAP activity in control and treated rats (**d**). N = 6, \**P* \< 0.05 vs. control group, ^\#^ *P* \< 0.05 vs. treated groups

AST, ALT, ALP and LDH levels were reduced following treatment compared to the control. These serum enzymes were significantly reduced at higher concentration of Ir in this study. Treatment showed increased AST, ALT, ALP and LDH levels compared to the standard control, but lesser than model control which indicates that treatment had a significant effect on the reduction of these enzymes (Figs. [2](#Fig2){ref-type="fig"}, [3](#Fig3){ref-type="fig"}, [4](#Fig4){ref-type="fig"}, [5](#Fig5){ref-type="fig"}, P \< 0.05). No pathology was found in the sham group. Liver histology showed the normal cellular architecture, and there was no congestion and necrosis. Liver cells were arranged in the cord. Several portal tracks were observed in the liver histology. Dilated sinusoids and veins were seen, as well as inflammation and necrosis was found in the control group (Fig. [6](#Fig6){ref-type="fig"}). However, the Ir treatment significantly reduced these abnormalities compared.Fig. 2Ir attenuated serum AST enzyme level. Values are expressed IU/L. Results are shown mean with SEM. N = 6, \**P* \< 0.05 vs. control group, ^\#^ *P* \< 0.05 vs. treated groups Fig. 3Ir attenuated serum ALT enzyme level. Values are expressed IU/L. Results are shown mean with SEM. N = 6, \**P* \< 0.05 vs. control group, ^\#^ *P* \< 0.05 vs. treated groups Fig. 4Ir attenuated serum ALP enzyme level. Values are expressed IU/L. Results are shown mean with SEM. N = 6, \**P* \< 0.05 vs. control group, ^\#^ *P* \< 0.05 vs. treated groups Fig. 5Ir attenuated serum LDH enzyme level. Values are expressed IU/L. Results are shown mean with SEM. N = 6, \**P* \< 0.05 vs. control group, ^\#^ *P* \< 0.05 vs. treated groups Fig. 6Ir attenuated altered cell morphology. Normal cellular architecture, and no congestion and necrosis (group I). Inflammation, congestion, and necrosis (group II). Attenuated inflammation, congestion, and necrosis (group III and IV). The representative images were obtained from six independent experiments

IL-6 and TNF-α levels were determined to understand the effect of an extract of Ir on inflammation. IL-6 and TNF-α levels were significantly increased 284.36 and 397.85% in the control rats compared to the sham. However, the treatment of extracts of Ir significantly reduced the IL-6 level to 26.26 and 54.25% in group III and group IV respectively. The TNF-α concentration was reduced to 47.08 and 67.17% in group III and group IV respectively (Fig. [7](#Fig7){ref-type="fig"}, P \< 0.05). Reduced level of cytokines revealed that extract of Ir possesses hepato-protective activity in hepatic ischemic/reperfusion injury in rats.Fig. 7Ir attenuated serum IL-6 and TNF-α level. Values are expressed as pg/mL. The results are expressed as +SEM, N = 6, \**P* \< 0.05 vs. control group, ^\#^ *P* \< 0.05 vs. treated group

To understand the effect of Ir on protein expression of p54, bax and bcl-2, we carried out western blot analysis. Protein expression of p54, bax and bcl-2 were significantly altered compared to the control. The bcl-2 protein expression was reduced to 0.54 fold in control compared to the sham control. Ir treatment significantly increased bcl-2 expression 0.45 and 0.87 folds in group III and group IV respectively. The p53 protein expression was reduced to 0.08-fold in control compared to the sham control. Ir treatment significantly reduced p53 expression 0.34- and 0.47-folds in group III and group IV respectively. The bax protein expression was reduced to 0.04-fold in control compared to the sham control. Ir treatment significantly reduced bax expression 0.22- and 0.41-folds in group III and group IV respectively (Fig. [8](#Fig8){ref-type="fig"}, P \< 0.05). Renormalization of cancer apoptotic gene expression revealed that the extract of Ir possesses hepato-protective activity in hepatic ischemic/reperfusion injury in rats.Fig. 8The effect of Ir on the protein expression of p53, bcl-2 and bax. The western blot (**a**) and presentative images of p53, bcl-2 and bax (**b**). The results are expressed as +SEM, N = 6, \**P* \< 0.05 vs. control group, ^\#^ *P* \< 0.05 vs. treated groups

Immunohistochemistry revealed the effect of Ir on p53, bax and bcl-2 expression. The p53, bax and bcl-2 protein expression were reduced in control compared to the sham control. Ir treatment significantly reduced the p53 and bax expression compared to the control, whereas bcl-2 expression was dramatically increased compared to the control. The effect was found in a dose-dependent manner (Fig. [9](#Fig9){ref-type="fig"}).Fig. 9Immunofluorescence of p53, bcl-2 and bax. The representative images were obtained from six independent experiments. Scale bar is 60 µm

Discussion {#Sec22}
==========

The GC--MS and HPLC/MS analysis was used to get preliminary data on the composition of Ir extracts in the present study. The presence of alkaloids, phenols and flavonoids in the extract of Ir may induce directly or indirectly to neutralize the oxidants and activation of free radical scavenging system (Dinkova-Kostova [@CR8]). Zheng and Wang ([@CR36]) have reported that the degree of flavonoid and polyphenol abundance contains positive correlation to its free radical scavenging and antioxidant potential. Our results agree with findings of Mohan and Gupta ([@CR20]) who have stated that the right antioxidant activity of extracts of Ir in ABTS and FRAP assays. Our results agreed with findings of Manipuri et al. ([@CR18]) who have reported that the reduced level of serum hepatic enzymes and renormalization of altered cellular morphology following treatment of Ir in hepatic I/R injury in rats.

To understand the effect of Ir on protein expression of p54, bax and bcl-2, we carried out western blot analysis. Protein expression of p54, bax and bcl-2 were significantly altered compared to the control. Renormalization of cancer apoptotic gene expression revealed that the extract of Ir possesses hepato-protective activity in hepatic ischemic/reperfusion injury in rats. Immunohistochemistry revealed the effect of Ir on p53, bax and bcl-2 expression. The p53, bax and bcl-2 protein expression were reduced in control compared to the sham control. Ir treatment significantly reduced the p53 and bax expression compared to the control, whereas bcl-2 expression was dramatically increased compared to the control. The effect was found in a dose-dependent manner. The medicinal property of Ir has been extensively studied in the ayurvedic system in rodents and human models (Miller [@CR19]). Cardioprotective effect of Ir has been reported against isoproterenol-induced myocardial infarction (Ojha et al. [@CR25]).

In summary, the administration of extracts of Ir significantly increased total phenolic content and free radical scavenging activity. Altered cellular morphology, cytokines and AST, ALT, ALP, and LDH were returned to near normal level. Also, the protein expression of p53, bax, and bcl-2 were also returned to near normal level. Taking all these data together, it is suggested that the extracts of Ir may be a potential therapeutic agent for providing several beneficial effects in hepatic I/R injury following orthotopic liver transplantation.
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